Stress, anxiety, and illness perception in patients experiencing delay in operative care due to the COVID-19 pandemic

Delayed and unmet prescription drug access linked to elevated anxiety symptoms during COVID-19: Retrospective findings from the NLSY79 child and young adult cohort

“…The observed association between delayed and unmet access to prescription drugs and increased anxiety-related issues corresponds with the wider interruptions in healthcare access and anxiety linked to COVID-19. 26 , 27 , 28 The factors responsible for the association between delayed and unmet access to prescription drugs and increased anxiety-related symptoms are likely varied. People may have faced compounded issues, particularly in managing the unpredictability of an international health emergency while grappling with disruptions in pharmacological schedules.…”